Mirae Asset Global Etfs Holdings Ltd. Artivion, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Artivion, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,559 shares of AORT stock, worth $637,517. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,559
Previous 21,832
3.33%
Holding current value
$637,517
Previous $581,000
11.7%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$79.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$77.4 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$66.7 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.14B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...